CELLECT BIOTECHNOLOGY LTD's ticker is APOP and the CUSIP is 15116C102. A total of 11 filers reported holding CELLECT BIOTECHNOLOGY LTD in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2019 | $5,000 | 0.0% | 9,740 | 0.0% | 0.00% | – |
Q2 2019 | $5,000 | -50.0% | 9,740 | 0.0% | 0.00% | – |
Q1 2019 | $10,000 | -50.0% | 9,740 | 0.0% | 0.00% | – |
Q4 2018 | $20,000 | -56.5% | 9,740 | 0.0% | 0.00% | – |
Q3 2018 | $46,000 | -34.3% | 9,740 | 0.0% | 0.00% | – |
Q2 2018 | $70,000 | +12.9% | 9,740 | 0.0% | 0.00% | – |
Q1 2018 | $62,000 | -8.8% | 9,740 | 0.0% | 0.00% | – |
Q4 2017 | $68,000 | -11.7% | 9,740 | 0.0% | 0.00% | – |
Q3 2017 | $77,000 | +234.8% | 9,740 | +247.9% | 0.00% | – |
Q2 2017 | $23,000 | – | 2,800 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DEUTSCHE BANK AG\ | 500 | $4,000 | 0.00% |
CITIGROUP INC | 2,800 | $23,000 | 0.00% |
MORGAN STANLEY | 9,864 | $80,000 | 0.00% |
Psagot Value Holdings Ltd. | 186 | $1,000 | 0.00% |
Tower Research Capital LLC (TRC) | 300 | $2,000 | 0.00% |
UBS Group AG | 1,786 | $14,000 | 0.00% |